Millions of Americans rely on over-the-counter medicines known as OTCs to treat conditions such as allergies, sleep issues, or pain. Following the COVID-19 pandemic, OTCs have become an even more essential part of the treatment toolbox as people increasingly look for cost effective ways to take greater control of their health. Today, we're going to take a look at the value created by OTC medicines to the US healthcare system as we walk through some of the top findings from CHPA's latest OTC value study,

Note: IRI has since changed its name to Circana

With special guests:

• Kristin Hornberger EVP, Practice Leader Consumer Healthcare, Circana
• Mindy Albuck, Principal and Team Lead, Client Insights, Circana
• David Spangler, Senior Vice President, Legal, Government Affairs & Policy, CHPA

Hosted by:

Anita Brikman, Senior Vice President, Communications & Public Affairs, CHPA; and Executive Director, CHPA Educational Foundation